These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5076477)

  • 61. Side effects and complications in lithium therapy.
    Svestka J; Náhunek K; Rodová A
    Act Nerv Super (Praha); 1970; 12(3):264-5. PubMed ID: 5457452
    [No Abstract]   [Full Text] [Related]  

  • 62. [Treatment of outpatients with high doses of haloperidol].
    Shopsin B; Kline N
    Acta Psiquiatr Psicol Am Lat; 1981 Jul; 27(3):236-42. PubMed ID: 7348083
    [No Abstract]   [Full Text] [Related]  

  • 63. Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia.
    Mackin P; Gallagher P; Watson S; Young AH; Ferrier IN
    Aust N Z J Psychiatry; 2007 Apr; 41(4):321-6. PubMed ID: 17464718
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effect of pirprofen and indomethacin on the effects of oxprenolol and furosemide].
    Sörgel F; Hemmerlein M; Lang E
    Arzneimittelforschung; 1984; 34(10):1330-2. PubMed ID: 6335039
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Clinical significance of depot fluphenazine decanoate in therapy of acute psychotic disorders].
    Ngui PW
    Seishin Shinkeigaku Zasshi; 1983; 85(9):635-9. PubMed ID: 6676769
    [No Abstract]   [Full Text] [Related]  

  • 66. [The pharmacologic properties and therapeutic effectiveness of the new antidepressant preparation Azaphen].
    Mashkovskii MD; Polezhaeva AI; Avrutskii GIa; Vertozgadova OP; Smulevich AB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(8):1234-8. PubMed ID: 5392529
    [No Abstract]   [Full Text] [Related]  

  • 67. Effect of oxprenolol on stage-fright in musicians.
    James IM; Griffith DN; Pearson RM; Newbury P
    Lancet; 1977 Nov; 2(8045):952-4. PubMed ID: 72290
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Letter: Oxprenolol and levodopa in parkinsonian patients.
    Sandler M; Fellows LE; Calne DB; Findley LJ
    Lancet; 1975 Jan; 1(7899):168. PubMed ID: 46086
    [No Abstract]   [Full Text] [Related]  

  • 69. Behavioral and pharmacological effects of a new psychoactive agent.
    Sletten IW; Pichardo X; Gershon S
    Curr Ther Res Clin Exp; 1965 Oct; 7(10):609-16. PubMed ID: 4954886
    [No Abstract]   [Full Text] [Related]  

  • 70. [Effective treatment of theophylline poisoning using a beta adrenergic blockader].
    Katona Z
    Orv Hetil; 1990 Jul; 131(29):1591-2. PubMed ID: 1975436
    [No Abstract]   [Full Text] [Related]  

  • 71. [Electrophysiologic study of injectable oxprenolol].
    Chauvin M; Brechenmacher C; Voegtlin R
    Cardiology; 1981; 68 Suppl 1():123-6. PubMed ID: 7296570
    [No Abstract]   [Full Text] [Related]  

  • 72. Reducing the somatic manifestations of anxiety by beta-blockade--a study of stage fright.
    James IM; Pearson RM; Griffith DN; Newbury P; Taylor SH
    J Psychosom Res; 1978; 22(4):327-37. PubMed ID: 739420
    [No Abstract]   [Full Text] [Related]  

  • 73. [Determination of oxprenolol in human blood plasma by gas chromatography].
    Nambara T; Akiyama S; Kurata M
    Yakugaku Zasshi; 1973 Apr; 93(4):439-41. PubMed ID: 4738513
    [No Abstract]   [Full Text] [Related]  

  • 74. [The EEG of patients with acute manic psychoses before, during and after treatment with high doses of d-propranolol and dl-propranolol (author's transl)].
    Coulin K; Simon O; Emrich HM; von Zerssen D
    Arch Psychiatr Nervenkr (1970); 1982; 231(4):323-31. PubMed ID: 7052014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Treatment of acute schizophrenic psychosis with beta-adrenergic blocking agents (author's transl)].
    Rackensperger W; Gaupp R; Mattke DJ; Schwarz D; Stutte KH
    Arch Psychiatr Nervenkr (1970); 1974 Jun; 219(1):29-36. PubMed ID: 4152285
    [No Abstract]   [Full Text] [Related]  

  • 76. [Use of certain cardiological drugs in the treatment of schizophrenia: review of the literature].
    Llorca PM; Wolf MA
    J Psychiatry Neurosci; 1991 Mar; 16(1):19-24. PubMed ID: 1675588
    [No Abstract]   [Full Text] [Related]  

  • 77. [The effect of the beta-adrenergic blocking agent propranolol in mania (author's transl)].
    Rackensperger W; Fritsch W; Schwarz D; Stutte KH; Zerssen D
    Arch Psychiatr Nervenkr (1970); 1976 Oct; 222(2-3):223-43. PubMed ID: 999494
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Action of d-propranolol in manic psychoses.
    Möller HJ; von Zerssen D; Emrich HM; Kissling W; Cording C; Schietsch HJ; Riedel E
    Arch Psychiatr Nervenkr (1970); 1979 Dec; 227(4):301-17. PubMed ID: 549537
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Therapy of excited psychoses using a beta receptor blockader (oxprenolol) in high dosage].
    Volk W; Bier W; Braun JP; Grüter W; Spiegelberg U
    Nervenarzt; 1972 Sep; 43(9):491-2. PubMed ID: 5076477
    [No Abstract]   [Full Text] [Related]  

  • 80. [Effect of oxprenolol on the dynamics of left ventricular contraction in patients with coronary disease].
    Hoszowski K; Prosińska-Kibler M
    Kardiol Pol; 1972; 15(4):433-6. PubMed ID: 4641913
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.